PS

Priyanka Suresh Pujare

Active Director Designated Partner DIN 10045272
DIN 10045272 First appointment Feb 2023 Primary industry Service
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Priyanka Suresh Pujare

Data last updated:

Priyanka Suresh Pujare is a Designated Partner at Mandovi Vetminds Pharma Llp (since 2023). The company operates in Service.

DIN 10045272
Primary Designation Designated Partner
Industry Service
First Appointment 10 Feb 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner10 Feb 20232023Active

Board colleagues of Priyanka Suresh Pujare

Directorship timeline

Open interactive timeline →
Mandovi Vetminds Pharma Llp
Premium access

Shareholding and investment profile for Priyanka Suresh Pujare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyanka Suresh Pujare

Priyanka Suresh Pujare currently holds 1 directorship: Mandovi Vetminds Pharma Llp (Designated Partner, since 10 Feb 2023).

Priyanka Suresh Pujare was first appointed on 10 Feb 2023 as Designated Partner at Mandovi Vetminds Pharma Llp.

The current boards of Priyanka Suresh Pujare's companies include Dineshsingh Baldevsingh Sulhyan (Mandovi Vetminds Pharma Llp), Mayur Chandrakant Kowjalgi (Mandovi Vetminds Pharma Llp), Sairaj Rajesh Kenny (Mandovi Vetminds Pharma Llp), Shrikant Murlidhar Joshi (Mandovi Vetminds Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available